Artificial intelligence models are accelerating drug and vaccine discovery by enhancing understanding of mRNA translation efficiency and protein synthesis. Recent AI systems predict how mRNA sequences translate into proteins across various cell types, facilitating targeted therapeutic design for viral infections, cancers, and genetic diseases. Such tools are expected to expedite timelines and improve efficacy in mRNA-based medicine development, marking significant progress in computational biology and pharmaceutical innovation.